Haematopoetic stem cells from the bone marrow. © 123rf.com/ royaltystockphoto

Kiadis Pharma NV has entered a definitive agreement to acquire US-based CytoSen Therapeutics, Inc. in order to create a leader in cell-based cancer immunotherapy.

© University of Glasgow

Researchers at University of Glasgow report that modulation of a specific GPCR results in health benefits normally mediated by a healthy gut microbiome.

Chronic inflammatory disease company Immunic Therapeutics starts Nasdaq-trade following merger with Vital Therapies.
 

Adherend Chinese hamster ovary (CHO) cells in cell culture flask (phase contrast microscopic view). Picture: Alcibiades

Biomanufacturing – either for production of biologics or bio-based everyday products – has traditionally suffered from the unpredictably variable response of production cell lines to external stimuli. Synthetic biology groups now wish to create a network of biofoundries that aim to establish reproducibility standards from process design to product purification and – in the long term – intend to switch from cell-based to cell-free bioproduction.

davidchiswellsml.png

IGEM Therapeutics, an immuno-oncology company developing novel immunoglobulin E (IgE) antibodies to treat cancer, announces that Dr David Chiswell will be joining IGEM as a Non-Executive Chairman effective immediately.

eb_2019_spring_josefplank.png

Within the record time of nine months, the Austrian government, together with experts of the Austrian Bioeconomy plattform and the sustainability think tank Denkstatt, has worked out a national bioeconomy strategy. European Biotechnology spoke with Josef Plank, Secretary General at the leading Federal Ministry of Sustainability about the focus and ambition of the national initiative.

A pensive mother. © C.D. Patel

Scientists from Belgium and the US have found a way to prevent the devasting consequences of herpes infections for newborn babies.

© 123rf.com/guniita
Evotec SE and Indivumed GmbH have entered into a drug R&D collaboration aimed at developing first-in-class colorectal cancer treatments.
96-well EchoLUTION DNA extraction. 4 randomly chosen DNA preparations from 8 different mouse organ tissues (12 replicates each) were analyzed on an agarose gel and applied to qPCR detection. All samples were detected with high reproducibility (standard deviation

BioEcho develops single-spin and 96-well kits for the isolation of DNA. Their proprietary EchoLUTION single-step technology avoids the use of inhibitory process reagents resulting in increased sensitivity and reliability of downstream analyses. Therefore, the risk of inhibition or complete failure of PCR applications is eliminated. The process does not require washing steps and is significantly faster than commonly used bind-wash-elute methods.

© Theranexus

Lyon-based neurology specialist Theranexus SA has launched a new bioinformatics partnership with systems biology data analysts from Dyliss (Dynamics, Logics and Inference for biological Systems and Sequences).